Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy, Safety, and Immunogenicity of RotaTeq Among Infants in Asia and Africa.

Trial Profile

Efficacy, Safety, and Immunogenicity of RotaTeq Among Infants in Asia and Africa.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jul 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary)
  • Indications Gastroenteritis; Rotavirus infections
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms COMPLETED
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 17 Oct 2016 Results of a post-hoc analysis were published in the Pediatric Infectious Disease Journal
    • 06 Aug 2010 Results in children from Africa published in Lancet.
    • 06 Aug 2010 Results in children from Asia published in Lancet.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top